Multiple acute stroke syndrome: Marker of embolic disease?, Neurology, vol.54, issue.3, pp.674-678, 2000. ,
DOI : 10.1212/WNL.54.3.674
Significance of Acute Multiple Brain Infarction on Diffusion-Weighted Imaging, Stroke, vol.31, issue.3, pp.688-694, 2000. ,
DOI : 10.1161/01.STR.31.3.688
Multiple acute cerebral infarcts on diffusion-weighted imaging and risk of recurrent stroke, Neurology, vol.63, issue.7, pp.1317-1319, 2004. ,
DOI : 10.1212/01.WNL.0000140490.22251.B6
Mechanism of multiple infarcts in multiple cerebral circulations on diffusion-weighted imaging, Journal of Neurology, vol.63, issue.7, pp.924-930, 2007. ,
DOI : 10.1212/01.WNL.0000140490.22251.B6
Early and late recurrence of ischemic lesion on MRI: Evidence for a prolonged stroke-prone state?, Neurology, vol.63, issue.12, pp.2261-2265, 2004. ,
DOI : 10.1212/01.WNL.0000147295.50029.67
Quantitative T2 Values Predict Time From Symptom Onset in Acute Stroke Patients, Stroke, vol.40, issue.5, pp.1612-1616, 2009. ,
DOI : 10.1161/STROKEAHA.108.542548
Negative fluid-attenuated inversion recovery imaging identifies acute ischemic stroke at 3 hours or less, Annals of Neurology, vol.29, issue.6, pp.724-732, 2009. ,
DOI : 10.1038/jcbfm.1985.34
MRI predicts time from symptom onset in acute stroke patients: implications for patients with unknown onset time, Radiology, 2010. ,
Acute ischemic lesions of varying ages predict risk of ischemic events in stroke/TIA patients, Neurology, vol.68, issue.6, pp.415-419, 2007. ,
DOI : 10.1212/01.wnl.0000252938.76188.52
Acute brain MRI???DWI patterns and stroke recurrence after mild-moderate stroke, Journal of Neurology, vol.63, issue.6, pp.947-953, 2010. ,
DOI : 10.1212/01.WNL.0000140490.22251.B6
Risk for Intracranial Hemorrhage after Tissue Plasminogen Activator Treatment for Acute Myocardial Infarction, Annals of Internal Medicine, vol.129, issue.8, pp.597-604, 1998. ,
DOI : 10.7326/0003-4819-129-8-199810150-00002
Guidelines for the Early Management of Patients With Ischemic Stroke: 2005 Guidelines Update A Scientific Statement From the Stroke Council of the American Heart Association/American Stroke Association, Stroke, vol.36, issue.4, pp.916-923, 2005. ,
DOI : 10.1161/01.STR.0000163257.66207.2d
Conclusions:, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, vol.27, issue.03 ,
DOI : 10.1056/NEJM199512143332401
Available at: http://emc.medicines.org.uk/emc, p.308 ,
Bleeding Risk Analysis in Stroke Imaging Before ThromboLysis (BRASIL): Pooled Analysis of T2*-Weighted Magnetic Resonance Imaging Data From 570 Patients, Stroke, vol.38, issue.10, pp.2738-2744, 2007. ,
DOI : 10.1161/STROKEAHA.106.480848
Clinical importance of microbleeds in patients receiving IV thrombolysis, Neurology, vol.65, issue.8, pp.1175-1178, 2005. ,
DOI : 10.1212/01.wnl.0000180519.27680.0f
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke, New England Journal of Medicine, vol.359, issue.13, pp.1317-1329, 2008. ,
DOI : 10.1056/NEJMoa0804656
Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, Stroke, vol.24, issue.1, pp.35-41, 1993. ,
DOI : 10.1161/01.STR.24.1.35
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS), JAMA: The Journal of the American Medical Association, vol.274, issue.13, pp.1017-1025, 1995. ,
DOI : 10.1001/jama.274.13.1017
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study, The Lancet, vol.369, issue.9558, pp.275-282, 2007. ,
DOI : 10.1016/S0140-6736(07)60149-4
Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II), The Lancet, vol.352, issue.9136, pp.1245-1251, 1998. ,
DOI : 10.1016/S0140-6736(98)08020-9
Regional Very Low Cerebral Blood Volume Predicts Hemorrhagic Transformation Better Than Diffusion-Weighted Imaging Volume and Thresholded Apparent Diffusion Coefficient in Acute Ischemic Stroke, Stroke, vol.41, issue.1, pp.82-88, 2010. ,
DOI : 10.1161/STROKEAHA.109.562116
Combination of T2*W and FLAIR Abnormalities for the Prediction of Parenchymal Hematoma Following Thrombolytic Therapy in 100 Stroke Patients, Journal of Neuroimaging, vol.105, issue.suppl 2, pp.311-316, 2009. ,
DOI : 10.1007/978-3-7091-6467-9_4
Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke, Stroke, vol.37, issue.10, pp.2463-2466, 2006. ,
DOI : 10.1161/01.STR.0000239321.53203.ea
Risk Factors of Symptomatic Intracerebral Hemorrhage After tPA Therapy for Acute Stroke, Stroke, vol.38, issue.8, pp.2275-2278, 2007. ,
DOI : 10.1161/STROKEAHA.106.480475
Focal Fluid-Attenuated Inversion Recovery Hyperintensity Within Acute Diffusion-Weighted Imaging Lesions Is Associated With Symptomatic Intracerebral Hemorrhage After Thrombolysis, Stroke, vol.39, issue.12, pp.3424-3426, 2008. ,
DOI : 10.1161/STROKEAHA.108.516740
Tissue Plasminogen Activator for Acute Ischemic Stroke in Clinical Practice: A Meta-Analysis of Safety Data, Stroke, vol.34, issue.12, pp.2847-2850, 2003. ,
DOI : 10.1161/01.STR.0000101752.23813.C3
Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials, Lancet, vol.363, pp.768-774, 2004. ,
Comparison of MRI and CT for detection of acute intracerebral hemorrhage Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group, JAMA Stroke, vol.29228, issue.33, pp.1823-18302109, 1997. ,
Symptomatic hemorrhage after alteplase therapy not due to silent ischemia, BMC Neurology, vol.29, issue.9, p.1, 2001. ,
DOI : 10.1161/01.STR.29.8.1504
Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials, The Lancet, vol.375, issue.9727, pp.1695-1703, 2010. ,
DOI : 10.1016/S0140-6736(10)60491-6